Chronic therapeutic anticoagulation is associated with decreased thrombotic complications in SARS-CoV-2 infection.

Daniel J LachantNeil A LachantPeter KouidesStephen RappaportParitosh PrasadR James White

Published in: Journal of thrombosis and haemostasis : JTH (2020)

Our uncontrolled findings suggest that chronic anticoagulation at the time of infection may protect against thrombotic complications and decrease disease severity.

Keyphrases

atrial fibrillation
venous thromboembolism
risk factors
drug induced
sars cov
respiratory syndrome coronavirus